Regulatory Landscape: Navigating Approval Pathways for Live Biotherapeutics
The Human Microbiome Based Drugs Diagnostics Market operates within an evolving regulatory framework that presents unique challenges and opportunities for developers of microbiome-based therapeutics and diagnostics. Unlike conventional small molecule or biologic drugs, live biotherapeutic products (LBPs) consist of living microorganisms that interact dynamically with host physiology and...
0 Commenti 0 condivisioni 6 Views 0 Anteprima